ERBB2 and urinary bladder carcinoma: Furthermore, 19/67 non-amplified samples had a high mRNA expression (in the 3rd tertile) and 13/83 had an IHC Score 3, suggesting that gene amplification is not the sole driver of high Her2 expression in bladder cancer.